| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| An economic theory of church strictness |
0 |
0 |
0 |
368 |
0 |
0 |
1 |
1,311 |
| Approval Rules for Sequential Horizontal Mergers |
0 |
0 |
0 |
95 |
1 |
1 |
2 |
591 |
| Bargaining and idle public sector capacity in health care |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
71 |
| Competition Policy in Portugal |
0 |
1 |
1 |
149 |
1 |
2 |
2 |
570 |
| Contractual design and public-private parternships for hospitals |
0 |
0 |
0 |
24 |
0 |
0 |
0 |
88 |
| Counterfactual Analysis of Bank Mergers |
0 |
0 |
0 |
108 |
1 |
1 |
1 |
306 |
| Double Coverage and Health Care Utilisation:Evidence from Quantile Regression |
0 |
0 |
0 |
56 |
0 |
0 |
0 |
259 |
| Double coverage and demand for health care: Evidence from quantile regression |
0 |
0 |
0 |
139 |
0 |
0 |
1 |
365 |
| Economies of scale and scope in the provision of diagnostic techniques and therapeutic services in Portuguese hospitals |
0 |
0 |
0 |
3 |
0 |
1 |
2 |
66 |
| Economies of scale and scope in the provision of diagnostic techniques and therapeutic services in Portuguese hospitals |
0 |
0 |
0 |
127 |
0 |
0 |
0 |
499 |
| Ex-ante Moral Hazard and Primary Prevention, evidence from Portugal |
0 |
0 |
1 |
165 |
0 |
2 |
7 |
578 |
| Health Care and Health Outcomes of Migrants: Evidence from Portugal |
0 |
1 |
1 |
41 |
0 |
1 |
1 |
117 |
| Health Care and Health Outcomes of Migrants: Evidence from Portugal |
0 |
1 |
1 |
33 |
0 |
1 |
1 |
140 |
| Health Care and Health Outcomes of Migrants: Evidence from Portugal |
0 |
0 |
0 |
35 |
0 |
1 |
1 |
126 |
| Hospital production in a national health service: the physician's dilemma |
0 |
0 |
0 |
160 |
0 |
1 |
1 |
661 |
| How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? |
0 |
0 |
0 |
57 |
0 |
0 |
0 |
163 |
| How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? |
0 |
0 |
0 |
45 |
0 |
0 |
0 |
214 |
| Incentives for R&D: Payment Options and Pricing Challenges |
1 |
1 |
2 |
31 |
1 |
1 |
3 |
47 |
| Industrial Policy and Firm Heterogeneity |
0 |
0 |
0 |
89 |
1 |
2 |
2 |
415 |
| Industrial policy and firm heterogeneity |
0 |
0 |
0 |
237 |
0 |
1 |
1 |
766 |
| Keeping Both Eyes Wide Open: The Life of a Competition Authority Among Sectoral Regulators |
0 |
0 |
0 |
46 |
0 |
0 |
0 |
177 |
| Keeping Both Eyes Wide Open: The Life of a Competitive Authority among Sectoral Regulators |
0 |
0 |
0 |
30 |
1 |
2 |
2 |
100 |
| Moral Hazard and the Demand for Health Services: A Matching Estimator Approach |
0 |
0 |
0 |
196 |
0 |
0 |
0 |
772 |
| Moral hazard and the demand for health services: a matching estimator approach |
0 |
0 |
0 |
345 |
1 |
1 |
2 |
1,209 |
| Negotiation Advantages of Professional Associations in Health Care |
0 |
0 |
0 |
197 |
0 |
0 |
1 |
1,560 |
| Negotiation Advantages of Professional Associations in Health Care |
0 |
0 |
0 |
5 |
0 |
0 |
1 |
78 |
| On insurance and the cost-sharing of pharmaceutical R&D |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
70 |
| On the Effects of Anti-dumping Legislation |
0 |
0 |
0 |
215 |
1 |
1 |
1 |
1,207 |
| PUBLIC AND PRIVATE PROVISION OF HEALTCH CARE |
0 |
0 |
0 |
164 |
0 |
0 |
1 |
593 |
| Preventive health care and payment systems to providers |
0 |
0 |
1 |
285 |
0 |
0 |
1 |
1,150 |
| Public and Private Provision of Health Care |
0 |
0 |
0 |
333 |
1 |
1 |
1 |
1,397 |
| Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools |
0 |
0 |
1 |
69 |
0 |
0 |
2 |
276 |
| Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools |
0 |
0 |
0 |
51 |
0 |
0 |
1 |
199 |
| Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools |
0 |
0 |
1 |
48 |
0 |
0 |
1 |
193 |
| Sectoral Regulators and the Competition Authority: Which Relationship is Best? |
0 |
0 |
0 |
209 |
0 |
0 |
0 |
449 |
| Selecting Negotiation Processes with Health Care |
0 |
0 |
0 |
153 |
0 |
0 |
0 |
862 |
| Selecting Negotiation Processes with Health Care Providers |
0 |
0 |
0 |
14 |
0 |
0 |
0 |
87 |
| Technological adoption in health care |
0 |
0 |
0 |
89 |
0 |
0 |
1 |
230 |
| Technological adoption in health care |
0 |
0 |
1 |
73 |
0 |
0 |
3 |
228 |
| Technological adoption in health care |
0 |
0 |
0 |
7 |
0 |
0 |
0 |
80 |
| Technological adoption in health care |
0 |
0 |
0 |
60 |
0 |
1 |
2 |
254 |
| The Impact of Mobile Phone Diffusion on the Fixed-Link Network |
0 |
0 |
2 |
600 |
1 |
1 |
4 |
2,533 |
| The Impact of the "Chunnel" on the Location of Production Activities |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2,236 |
| The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry |
0 |
0 |
0 |
188 |
0 |
1 |
4 |
623 |
| Universal Service and Entry: the Role of Uniform Pricing and Coverage Constraints |
0 |
0 |
0 |
202 |
1 |
1 |
2 |
669 |
| WAITING LISTS AND PATIENT SELECTION |
0 |
0 |
0 |
102 |
0 |
0 |
0 |
404 |
| Waiting Lists and Patient Selection |
0 |
1 |
1 |
137 |
1 |
2 |
4 |
572 |
| Waiting Lists and Patient Selection |
0 |
0 |
0 |
152 |
0 |
1 |
1 |
428 |
| Total Working Papers |
1 |
5 |
13 |
5,948 |
12 |
27 |
62 |
25,989 |
| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A equidade na utilização de cuidados de saúde em Portugal: Uma avaliação baseada em modelos de contagem |
0 |
0 |
1 |
202 |
0 |
0 |
5 |
912 |
| A tale of loss of privilege, resilience and change: the impact of the economic crisis on physicians and medical services in Portugal |
0 |
0 |
0 |
7 |
0 |
0 |
0 |
32 |
| An Economic Theory Of Church Strictness |
0 |
0 |
0 |
99 |
0 |
2 |
2 |
649 |
| Bargaining and idle public sector capacity in health care |
0 |
0 |
1 |
7 |
0 |
0 |
2 |
86 |
| Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic |
2 |
2 |
2 |
2 |
2 |
3 |
3 |
3 |
| Budget effects of health care 'vouchers' |
0 |
0 |
0 |
69 |
0 |
0 |
0 |
176 |
| COVID-19, Fake News, and Vaccines: Should Regulation Be Implemented? |
0 |
0 |
1 |
1 |
0 |
0 |
5 |
5 |
| Catastrophic healthcare expenditure – Drivers and protection: The Portuguese case |
0 |
1 |
1 |
55 |
0 |
1 |
1 |
145 |
| Competing for Foreign Direct Investment |
1 |
1 |
1 |
2 |
1 |
1 |
3 |
14 |
| Competition Effects of Price Liberalization in Insurance |
0 |
0 |
0 |
76 |
0 |
0 |
1 |
311 |
| Competition among health care providers: helpful or harmful? |
0 |
0 |
0 |
11 |
1 |
1 |
2 |
46 |
| Competition policy for health care provision in Portugal |
0 |
1 |
1 |
15 |
0 |
2 |
4 |
47 |
| Concerns and adjustments: How the Portuguese population met COVID-19 |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
15 |
| Conduct Effects of Gradual Entry Liberalization in Insurance |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
205 |
| Contractual design and PPPs for hospitals: lessons for the Portuguese model |
0 |
0 |
0 |
59 |
0 |
0 |
1 |
154 |
| Convergence and information technologies - the experience of Greece, Portugal and Spain |
0 |
0 |
0 |
66 |
0 |
0 |
0 |
228 |
| Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
2 |
| Counterfactual analysis of bank mergers |
0 |
1 |
1 |
38 |
1 |
2 |
6 |
143 |
| Cream-skimming, incentives for efficiency and payment system |
1 |
1 |
2 |
210 |
1 |
3 |
5 |
484 |
| Dedicated Pediatricians in Emergency Department: Shorter Waiting Times and Lower Costs |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
| Does a Tougher Competition Policy Reduce or Promote Investment? |
0 |
0 |
0 |
23 |
0 |
0 |
1 |
118 |
| Double health insurance coverage and health care utilisation: evidence from quantile regression |
0 |
0 |
0 |
33 |
0 |
1 |
1 |
186 |
| Economies of scale and scope in the provision of diagnostic techniques and therapeutic services in Portuguese hospitals |
0 |
0 |
0 |
25 |
0 |
1 |
1 |
116 |
| Editorial: Relaunch of the journal |
0 |
0 |
0 |
25 |
0 |
0 |
0 |
71 |
| Endogenous mergers and size asymmetry of merger participants |
0 |
0 |
1 |
119 |
1 |
1 |
2 |
383 |
| Entry and price competition in the over‐the‐counter drug market after deregulation: Evidence from Portugal |
0 |
0 |
0 |
7 |
0 |
0 |
2 |
42 |
| Estimating the impact of bank mergers: an application to the Portuguese banking system |
0 |
0 |
0 |
23 |
0 |
0 |
1 |
85 |
| Europeanization of EU member-state competition policy: The commission's leadership role |
0 |
0 |
1 |
13 |
0 |
0 |
1 |
72 |
| Freedom of Services and Competition in Insurance Markets: A Note |
0 |
0 |
0 |
50 |
0 |
0 |
0 |
284 |
| Health policy reform in tough times: The case of Portugal |
0 |
0 |
1 |
90 |
0 |
1 |
2 |
186 |
| How to Combine Public Spending with Fiscal Rigour? ‘Austerity by Stealth’ in Post-Bailout Portugal (2015-2019) |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
| How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? |
0 |
0 |
3 |
33 |
0 |
0 |
4 |
122 |
| Impact of Double Coverage on the Utilisation of Health Care |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
37 |
| Industrial Policy and Firm Heterogeneity |
0 |
0 |
0 |
52 |
0 |
0 |
3 |
253 |
| Looking behind the curtain--effects from modernization of European Union competition policy |
0 |
0 |
1 |
121 |
0 |
0 |
1 |
526 |
| Market equilibrium effects of incentives to foreign direct investment |
0 |
0 |
0 |
38 |
0 |
0 |
0 |
129 |
| Media Competition on the Internet |
0 |
0 |
2 |
156 |
0 |
1 |
7 |
564 |
| Merger policy in open economies |
0 |
0 |
1 |
176 |
0 |
1 |
5 |
404 |
| Mergers in the food retailing sector: An empirical investigation |
0 |
0 |
0 |
150 |
0 |
0 |
0 |
381 |
| Money for nothing? |
0 |
0 |
1 |
32 |
0 |
0 |
1 |
101 |
| Moral hazard and the demand for health services: A matching estimator approach |
0 |
0 |
0 |
104 |
0 |
2 |
3 |
407 |
| Multimarket competition in banking, with an example from the Portuguese market |
0 |
0 |
0 |
129 |
0 |
1 |
2 |
407 |
| Negotiation Advantages of Professional Associations in Health Care |
0 |
0 |
0 |
42 |
0 |
0 |
1 |
391 |
| On international cost-sharing of pharmaceutical R&D |
0 |
0 |
0 |
31 |
0 |
0 |
0 |
110 |
| On the effects of antidumping legislation |
0 |
0 |
1 |
29 |
0 |
0 |
1 |
203 |
| Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 |
0 |
0 |
0 |
39 |
0 |
0 |
1 |
157 |
| Portugal-European Union convergence: Some evidence |
0 |
0 |
0 |
71 |
0 |
0 |
0 |
269 |
| Post-entry expansion in banking: The case of Portugal |
0 |
0 |
1 |
56 |
0 |
0 |
1 |
197 |
| Preventive Health Care and Payment Systems |
0 |
0 |
1 |
106 |
1 |
1 |
2 |
628 |
| Public and Private Provision of Health Care |
0 |
0 |
0 |
262 |
0 |
0 |
2 |
1,136 |
| Quality decreases from introducing patient choice in a National Health Service |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
9 |
| Resilience Testing of Health Systems: How Can It Be Done? |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
3 |
| Sectoral Regulators and the Competition Authority: Which Relationship is Best? |
0 |
0 |
0 |
18 |
0 |
0 |
0 |
75 |
| Selecting health care providers: "Any willing provider" vs. negotiation |
0 |
0 |
0 |
35 |
0 |
0 |
0 |
230 |
| Settle for Now but Block for Tomorrow: The Deterrence Effects of Merger Policy Tools |
0 |
1 |
2 |
48 |
1 |
3 |
8 |
184 |
| Simplified Mathematical Modelling of Uncertainty: Cost-Effectiveness of COVID-19 Vaccines in Spain |
0 |
0 |
0 |
3 |
0 |
1 |
3 |
16 |
| Social Norms and the Paradox of Elections’ Turnout |
0 |
0 |
0 |
45 |
1 |
1 |
3 |
215 |
| Special Issue on Health Economics: Introduction |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9 |
| Strengthening vaccination programmes and health systems in the European Union: A framework for action |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
27 |
| Technological Adoption in Health Care – The Role of Payment Systems |
0 |
0 |
0 |
15 |
0 |
0 |
2 |
68 |
| Television News Scheduling Revisited |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
46 |
| The Effect of Firm Heterogeneity on R&D Competition |
0 |
0 |
0 |
16 |
0 |
0 |
0 |
63 |
| The black box of health care expenditure growth determinants |
0 |
0 |
1 |
12 |
0 |
1 |
6 |
482 |
| The good monopoly? A case for joint ownership of competing systems |
0 |
0 |
0 |
22 |
0 |
0 |
0 |
150 |
| The impact of pharmaceutical policy measures: An endogenous structural-break approach |
0 |
0 |
0 |
19 |
0 |
1 |
1 |
70 |
| The simple economics of risk‐sharing agreements between the NHS and the pharmaceutical industry |
0 |
1 |
2 |
50 |
0 |
3 |
6 |
164 |
| The slow and unnoticed changes in the funding mix |
0 |
0 |
0 |
44 |
0 |
0 |
0 |
170 |
| Transversal Agency and Crowding Out |
0 |
0 |
0 |
6 |
0 |
0 |
1 |
51 |
| United but divided: Policy responses and people’s perceptions in the EU during the COVID-19 outbreak |
0 |
0 |
1 |
5 |
0 |
0 |
1 |
16 |
| Universal Service and Entry: The Role of Uniform Pricing and Coverage Constraints |
0 |
0 |
0 |
140 |
0 |
0 |
1 |
521 |
| Universal service: does competition help or hurt? |
0 |
0 |
0 |
53 |
0 |
0 |
1 |
195 |
| Upcoding in a National Health Service: the evidence from Portugal |
0 |
0 |
2 |
16 |
0 |
1 |
6 |
59 |
| Waiting Lists and Patient Selection |
0 |
0 |
2 |
91 |
0 |
0 |
2 |
246 |
| Welfare decreasing endogenous mergers between producers of complementary goods |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
98 |
| Total Journal Articles |
4 |
9 |
36 |
3,619 |
10 |
38 |
133 |
14,798 |
LogEc is hosted by the
Örebro University School of Business.